Status:
COMPLETED
Determination of Sufentanil in Breast Milk of Puerpera
Lead Sponsor:
Fujian Medical University Union Hospital
Conditions:
Cesarean Section
Eligibility:
FEMALE
20-38 years
Phase:
PHASE4
Brief Summary
To determination of sufentanil in human breast milk during the administration of the sufentanil via the analgesic infusion pump and after the administration, to determine whether the breastfeeding aft...
Detailed Description
The concentration of sufentanil in milk was determined by LC-MS /MS method( liquid chromatography mass spectrometry).The separation was carried on Agilent ZORBAX Eclipse Plus C18 column(2.1×50 mm, 3.5...
Eligibility Criteria
Inclusion
- Aged 20yr to 38yr
- Height 155\~170 cm
- Weight 65\~85 Kg
- American Society of Anesthesiologists statuses I or II
- Normal cardiac and pulmonary function
- Undergoing elective Cesarean section
- Willing to provide breast milk
Exclusion
- pregnancy induced hypertension
- gestational diabetes
- gestational heart disease
Key Trial Info
Start Date :
August 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03764202
Start Date
August 1 2015
End Date
December 1 2017
Last Update
December 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.